Iterum Therapeutics Plc

(NASDAQ) ITRM

Current PriceN/A

Market CapN/A

Since IPO (2018)-100%

5 Year-100%

1 Year+0%

1 Month-99%

Iterum Therapeutics Plc Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$390.00K

Net Income (TTM)

-$26.96M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Apr 8, 2026

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Apr 8, 2026

ITRM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Iterum Therapeutics Plc

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Dublin, 2, IE

ITRM Financials

Key Financial Metrics (TTM)

Gross Margin

-171.28%

Operating Margin

-4261.79%

Net Income Margin

-5225.38%

Return on Equity

442.32%

Return on Capital

-45.10%

Return on Assets

-62.70%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$668.00K

Operating Income

-$20.29M

EBITDA

-$23.07M

Operating Cash Flow

-$19.91M

Capital Expenditure

-$14.57K

Free Cash Flow

-$19.93M

Cash & ST Invst.

$11.00M

Total Debt

$33.74M

Iterum Therapeutics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$390.00K

N/A

Gross Profit

$370.00K

N/A

Gross Margin

94.87%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$8.98M

-47.3%

EBITDA

-$8.05M

-50.2%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Total Cash

$11.00M

-24.1%

Total Debt

$33.74M

+50.4%

Accounts Receivable

$546.00K

+99.3%

Inventory

$1.15M

N/A

Long Term Debt

$33.45M

+283.3%

Short Term Debt

$281.00K

-98.0%

Return on Assets

-62.70%

N/A

Return on Invested Capital

-63.75%

N/A

Free Cash Flow

-$7.86M

-194.2%

Operating Cash Flow

-$7.85M

-193.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INTSIntensity Therapeutics, Inc.

INTSIntensity Therapeutics, Inc.$4.24+2.17%

IBIOiBio, Inc.

IBIOiBio, Inc.$1.68-4.00%

RLYBRallybio Corporation

RLYBRallybio Corporation$15.82-0.78%

PLURPluri Inc.

PLURPluri Inc.$2.11+0.96%

ANTXAN2 Therapeutics, Inc.

ANTXAN2 Therapeutics, Inc.$4.42-5.96%

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$2.50+0.81%

SONNSonnet BioTherapeutics Holdings, Inc.

SONNSonnet BioTherapeutics Holdings, Inc.$1.26-59.35%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

CLROClearOne

CLROClearOne$6.48+1.01%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

NOKNokia

NOKNokia$12.07-0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.95+0.05%

Questions About ITRM

What is the current price of Iterum Therapeutics Plc?

Iterum Therapeutics Plc is trading at N/A per share.

What is the 52-week range for Iterum Therapeutics Plc?

Over the past 52 weeks, Iterum Therapeutics Plc has traded between N/A and N/A.

How much debt does Iterum Therapeutics Plc have?

Iterum Therapeutics Plc total debt is unavailable.

How much cash does Iterum Therapeutics Plc have on hand?

Iterum Therapeutics Plc does not have cash on hand data available.

What is Iterum Therapeutics Plc’s dividend yield?

Iterum Therapeutics Plc does not currently have a dividend yield.

Iterum Therapeutics Plc

Iterum Therapeutics Plc Financials at a Glance

ITRM News

ITRM Reports Results

Why Iterum Therapeutics Stock Is Crashing Today

Why Iterum Therapeutics Stock Soared Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Iterum Therapeutics Plc

ITRM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Iterum Therapeutics Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ITRM

What is the current price of Iterum Therapeutics Plc?

What is the 52-week range for Iterum Therapeutics Plc?

How much debt does Iterum Therapeutics Plc have?

How much cash does Iterum Therapeutics Plc have on hand?

What is Iterum Therapeutics Plc’s dividend yield?

Premium Investing Services